Frontal Fibrosing Alopecia Clinical Trial
Official title:
Assessment of the Safety and Efficacy of Intralesional Platelet Rich Plasma in Reducing Scalp Symptoms and Promoting Hair Growth in Frontal Fibrosing Alopecia
The primary objective of this study is to assess the efficacy and safety of platelet rich plasma in reducing scalp symptoms and promoting hair growth in patients diagnosed with frontal fibrosing alopecia. Platelet rich plasma is an autologous blood product, and platelet rich plasma will be administered intralesionally for this study. The platelet rich plasma used for this study will be prepared using the Eclipse Easy Spin centrifuge.
The primary objective of this study is to assess the efficacy and safety of platelet rich plasma in reducing scalp symptoms and promoting hair growth in patients diagnosed with frontal fibrosing alopecia. The secondary objective of this study is subject self-assessment through the Dermatology Quality Life Index (DQLI) and Hair-Growth Assessment (HGA) as well as investigator-assessment from baseline. Platelet rich plasma is an autologous blood product, and platelet rich plasma will be administered intralesionally for this study. The platelet rich plasma used for this study will be prepared using the Eclipse Easy Spin centrifuge. The duration of this study for participants is 8 months, including an initial screening visit, 6 monthly treatment visits, and a follow-up visit. Subjects eligible for this study are those diagnosed with frontal-fibrosing alopecia via biopsy and clinical assessment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04409041 -
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
|
Phase 2 | |
| Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
| Enrolling by invitation |
NCT06202560 -
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
|
N/A | |
| Not yet recruiting |
NCT02467101 -
Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
|
N/A | |
| Recruiting |
NCT03422640 -
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
|
Phase 4 | |
| Completed |
NCT03346668 -
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
|
Early Phase 1 | |
| Active, not recruiting |
NCT03082560 -
Design and Validation of a New Assessment Tool for Lichen Planopilaris
|
||
| Completed |
NCT04342091 -
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
|
N/A | |
| Recruiting |
NCT06240351 -
A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
|
Phase 4 | |
| Completed |
NCT05332366 -
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
|
Phase 2 |